The GSv9TM Media and Feeds Platform was developed by Lonza specifically for GS-CHO cell lines. The platform complements Lonza’s proprietary GS Gene Expression System® for the production of therapeutic recombinant proteins and monoclonal antibodies.
- Highest protein quality with
- low levels of aggregates and fragments, and
- appropriate glycosylation pattern
- Chemically defined and animal component-free (CDACF)
- Developed by Lonza specifically for GS-CHO cell lines
- Increased antibody yield
Contact us at mediasales@lonza.com to discuss your requirements.